Question

A patient has been diagnosed with Primary Open Angle Glaucoma. On elliciting history, it was observed that the patient is a known case of bronchial asthma. What is the drug of choice for POAG in this patient?

• A. LMWH
• B. Increase beta blocker dose
• C. IV NTG Drip
• D. Add tap clopidogrel

Answer 1

The Correct Option is A

In the case of a patient diagnosed with Primary Open Angle Glaucoma (POAG) who has a history of bronchial asthma, it is vital to choose a treatment approach that does not exacerbate asthma symptoms. Typically, beta-blockers are used in managing POAG because they help reduce intraocular pressure by decreasing aqueous humor production. However, beta-blockers can precipitate bronchospasm in patients with a history of asthma, making them contraindicated or less ideal for such patients.

In this scenario, the drug choice provided, LMWH (Low Molecular Weight Heparin), is unrelated directly to glaucoma management; the options listed do not offer typical glaucoma treatments suitable for someone with asthma. However, since none of these options correctly relate to a safe glaucoma treatment where asthma is a concern, and given the context of POAG, alternatives like Prostaglandin analogs (e.g., Latanoprost), which are not on the list, are actually preferred in reality. For accuracy based on the options provided, focusing on educational concepts rather than incorrect matching is more beneficial.

Conclusion: Considering glaucoma treatment knowledge and the need to avoid beta-blockers in asthmatic patients, the best practice would involve choosing an alternative to beta-blockers, such as Prostaglandin analogs. Given that these options are not present, one must recognize the focus on educational mismatches and seek further correction and clarification in professional resources.